January 17, 2024

For decades, snack brands like Lay’s chips have emphasized the craveability of their products, declaring “Betcha can’t eat just one” to customers across countless marketing campaigns. But a growing number of Americans are challenging the validity of this classic slogan thanks to appetite-controlling drugs like Ozempic and Mounjaro. These pharmaceutical brands are quickly becoming big hits with consumers who want to reduce their compulsive eating habits, especially frequent snacking. According to one user, her grocery bills dropped by 20 percent Continue reading

Continue reading...

November 8, 2023

If you’ve taken an over-the-counter (OTC) nasal decongestant recently, you may have been upset to discover that it did not do much to relieve your clogged sinuses. In fact, recent studies by the Food and Drug Administration (FDA) show that most OTC decongestants work no better than a placebo. This video explains in detail how store shelves became filled with useless cold medicine, and ways that the FDA are working to make things right.


  1. Why do most OTC decongestants Continue reading
Continue reading...

April 5, 2015

Each year the pharmaceutical industry develops new drugs that go a long way towards fighting some of the world’s worst diseases. For instance, Bristol-Meyers Squibb recently received FDA (Food & Drug Administration) approval for Opdivo, a drug that significantly boosts the survival rate for sufferers of advanced melanoma. However, one major obstacle stands in the way of Opdivo’s ability to help patients: price. One year of treatment with the drug costs $150,000 per patient, an impossibly tall order for many Continue reading

Continue reading...